Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
175 participants
INTERVENTIONAL
2013-10-31
2019-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Primary hypothesis is that experimental subjects who participate in LEAF will demonstrate significantly greater improvements in psychological outcomes and will engage in more problem focused and positive appraisal forms of coping compared to the wait-list control condition.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Behavioral Activation for Dementia Caregivers
NCT03552159
Alzheimer's Caregiver Coping: Mental and Physical Health
NCT02317523
Learning Skills Together Family Caregiver Complex Intervention
NCT05846984
Primary Care-based Study of an Online Workshop for Family Caregivers of PLWD
NCT06928467
SAGE-LEAF: Reducing Burden in Alzheimer's Disease Caregivers Through Positive Emotion Regulation and Virtual Support
NCT05562583
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
positive affect intervention
positive affect intervention
Positive Affect
Six-session skill-building program designed to raise levels of positive emotion when skills are practiced over the duration of the program.
wait list control
wait list control
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Positive Affect
Six-session skill-building program designed to raise levels of positive emotion when skills are practiced over the duration of the program.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Must speak and read English
* Must have the ability to provide informed consent
Exclusion Criteria
* Evidence of severe cognitive impairment or active psychosis, as assessed by trained interviewers
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of California, San Francisco
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Glenna Dowling
Professor and chair, Department of Physiological Nursing
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Glenna A Dowling, PhD
Role: PRINCIPAL_INVESTIGATOR
University of California, San Francisco
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
UCSF
San Francisco, California, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Moskowitz JT, Cheung EO, Snowberg KE, Verstaen A, Merrilees J, Salsman JM, Dowling GA. Randomized controlled trial of a facilitated online positive emotion regulation intervention for dementia caregivers. Health Psychol. 2019 May;38(5):391-402. doi: 10.1037/hea0000680.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
A115168
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
14-13236
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.